Analysis-Can the new CVS CEO handle the Aetna challenge?
Analysts question if CVS's new CEO David Joyner can resolve Aetna's high medical costs and improve performance after ...
Strategic Leadership Change and Financial Realignment: Reasons Behind CVS Health’s Buy Rating
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CVS stock, giving a Buy rating today. Ann Hynes has given her Buy ...
Insurancenewsnet.com22h
STAT+: Behind CVS CEO’s ouster, a question: Do a pharmacy and a health insurer make sense together?
CVS Health is running out of time to answer an existential question about its strategy. This article is available to Insider Pro subscribers only. Sign in or register to be an Insider Pro and access ...
STAT23h
Behind CVS CEO’s ouster, a question: Do a pharmacy and a health insurer make sense together?
That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...
This 1 Challenge Will Test New CVS Health CEO David Joyner
The industry-wide rise in health coverage costs makes the company's Aetna unit the new leader's most difficult problem.
Can the new CVS CEO handle the Aetna challenge?
As CVS Health's new CEO David Joyner steps into the top job, Wall Street analysts and some investors are questioning whether ...
CVS names new CEO in the wake of layoffs and poor stock performance
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
STAT4d
Pharmalittle: We’re reading about a new CVS chief, obesity meds cutting overdoses, and more
CVS Health named David Joyner as its new chief, succeeding Karen Lynch at the helm of the struggling healthcare giant ...